SABSW 8-K 2026-10-13

SAB Biotherapeutics, Inc. (SABSW) 8-K dated 2026-10-13 — accession 0001193125-26-419769. This URL is the filing, not the SABSW hub.

SAB Biotherapeutics, Inc. (SABSW) warrant listed on NASDAQ.

SAB Biotherapeutics, Inc. filed a 8-K on 2026-10-13. Accession 0001193125-26-419769.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SABSW revenue for 2025-12-31 was $0. Net income was $13.3M. Revenue was down 100.0% from 2023-12-31 to 2025-12-31. SABSW currently screens at market cap $860.0K.

Not investment advice. The SABSW SEC hub lists recent forms. The stock page is the research view.